- Home
- IXHL vs LUMO Comparison
IXHL vs LUMO Comparison
Compare IXHL & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- LUMO
- Stock Information
- Founded
- IXHL 2001
- LUMO 2011
- Country
- IXHL Australia
- LUMO United States
- Employees
- IXHL N/A
- LUMO N/A
- Industry
- IXHL
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- LUMO Health Care
- Exchange
- IXHL Nasdaq
- LUMO Nasdaq
- Market Cap
- IXHL 39.2M
- LUMO 37.4M
- IPO Year
- IXHL N/A
- LUMO N/A
- Fundamental
- Price
- IXHL $2.00
- LUMO $4.34
- Analyst Decision
- IXHL
- LUMO Buy
- Analyst Count
- IXHL 0
- LUMO 4
- Target Price
- IXHL N/A
- LUMO $9.38
- AVG Volume (30 Days)
- IXHL 17.5K
- LUMO 133.0K
- Earning Date
- IXHL 11-14-2024
- LUMO 11-07-2024
- Dividend Yield
- IXHL N/A
- LUMO N/A
- EPS Growth
- IXHL N/A
- LUMO N/A
- EPS
- IXHL N/A
- LUMO N/A
- Revenue
- IXHL $86,000.00
- LUMO $2,205,000.00
- Revenue This Year
- IXHL $3,817.06
- LUMO $184.11
- Revenue Next Year
- IXHL $66.67
- LUMO N/A
- P/E Ratio
- IXHL N/A
- LUMO N/A
- Revenue Growth
- IXHL N/A
- LUMO 26.94
- 52 Week Low
- IXHL $1.50
- LUMO $1.37
- 52 Week High
- IXHL $8.47
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- IXHL 54.13
- LUMO 4.26
- Support Level
- IXHL $1.60
- LUMO $4.31
- Resistance Level
- IXHL $1.94
- LUMO $4.39
- Average True Range (ATR)
- IXHL 0.09
- LUMO 0.03
- MACD
- IXHL 0.04
- LUMO -0.44
- Stochastic Oscillator
- IXHL 83.33
- LUMO 0.00
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.